Background: The emergence of resistant tuberculosis (TB) is a major setback to the global control of the disease as the treatment of such resistance is complex and expensive. Use of direct detection of mutations by molecular methods could facilitate rapid diagnosis of resistance to offset diagnostic delays. We evaluated the performance of the Genotype MTBDRsl (Hain Life Sciences) for the detection of second line resistant TB directly from stored smear positive sputum sediments.
Methodology/principal Findings: The assay showed a diverse range of sensitivity and specificity, 91.26% [95% CI, 84-96] and 95.5% [95% CI, 87-99] for FQ (PPV ∼97% & NPV ∼ 87.67%), 56.19% [95%CI, 46-66] and 81% [95%CI, 66-91] for EMB (PPV ∼ 88.06% & NPV ∼ 43.21%) and 100% for SLD. Diagnostic accuracy for FQ, SLD and EMB was 94%, 100% and 63.51%, respectively. 1.17% (2/170) were heteroresistance strains, where the heteroresistance was linked to rrs gene. A varying rate of validity was observed 100% (170/170) for FQ, 94.11% (160/170) for EMB, 88.23% (150/170) for SLD.
Conclusions/significance: Genotype MTBDRsl is simple, rapid, economical assay that can be used to detect commonly known resistance associated with Fluoroquinolone, second line injectable drugs and ethambutol. The assay detects the targeted resistance in less time as compared to phenotypic DST. But due to low NPV to FQ (88%) and EMB (43.21%), the assay results must be interpreted in coordination with the phenotypic DST.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499545 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0049433 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: a retrospective genomic epidemiology study.
Sci Rep
August 2024
State TB Training and Demonstration Centre, Intermediate Reference Laboratory, Government Hospital for Chest Diseases, Puducherry, India.
Fluoroquinolone resistance is a major challenge in treating Multidrug-Resistant Tuberculosis globally. The GenoType MTBDRsl Ver 2.0, endorsed by the WHO, was used to characterize fluoroquinolone resistance.
View Article and Find Full Text PDFPattern and characteristics of mutations conferring resistance to second line drugs in Mycobacterium tuberculosis isolates of pulmonary and extrapulmonary TB samples.
Indian J Tuberc
July 2024
State TB Demonstration and Training Centre, Government of Rajasthan, Ajmer, India.
Background & Objectives: The purpose of present study is to analyse the distribution and pattern of genetic mutations in PRE-XDR-TB and extensive drug resistant Mycobacterium tuberculosis (XDR-TB) using second-line line probe assay and to compare them with different parameters.
Method: Sputum, Lymph node aspirate and cold accesses from patients with rifampicin resistant Tuberculosis were subjected to first line and second line Probe Assay (Genotype MTBDRsl by Hain Life Science, Germany) to assess additional drug resistance to fluroquinolones (Levofloxacin & Moxifloxacin) and Aminoglycosides (Amikacin, Ofloxacin and Kanamycin). The genetic mutation pattern was analysed and compared with demographic, clinical and other parameters.
TB drug susceptibility testing in high fluoroquinolone resistance settings.
IJTLD Open
May 2024
National TB Control Programme, Islamabad.
Article Synopsis
- The study addresses the rising resistance to the BPaLM drug regimen (bedaquiline, pretomanid, moxifloxacin) for tuberculosis (TB) in areas like Pakistan, proposing the use of Xpert MTB/XDR technology for early drug resistance detection.
- It involved a prospective analysis over six months using various testing methods, including Xpert MTB/RIF Ultra and next-generation sequencing, to evaluate resistance against key drugs.
- Results showed high sensitivity and specificity of MTB/XDR in detecting resistance, leading to a new diagnostic algorithm aimed at improving drug-resistant TB testing and treatment accessibility.
Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru.
PLoS One
June 2024
Universidad Peruana Cayetano Heredia, Lima, Perú.
Article Synopsis
- Whole Genome Sequencing (WGS) proves to be an effective method for detecting drug resistance and transmission clusters in multidrug-resistant tuberculosis (TB) in Peru, with a study analyzing 140 strains.
- WGS showed a high agreement (96.5%) with traditional testing methods (BACTEC MGIT) for detecting resistance to seven key anti-TB drugs, although some traditional results were invalid for 10-17% of cases.
- This method yielded quick results, averaging 11.5 days for WGS compared to 28.6-52.6 days for routine processes, and revealed that most strains belonged to a single lineage with low transmission cluster rates.
Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
PLoS One
May 2024
Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Background: The emergence of drug-resistant tuberculosis (DR-TB) has been a major obstacle to global tuberculosis control programs, especially in developing countries, including Ethiopia. This study investigated drug resistance patterns and associated mutations of Mycobacterium tuberculosis Complex (MTBC) isolates from the Amhara, Gambella, and Benishangul-Gumuz regions of Ethiopia.
Methods: A cross-sectional study was conducted using 128 MTBC isolates obtained from patients with presumptive tuberculosis (TB).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!